Mr. Haer graduated from Thiel College with a BS in Chemistry in 1965 and for two years did graduate work in physical chemistry at the University of Michigan. From 1967 to 1969 he worked for Gelman Instruments as a project manager, and from 1969 to 1970 he was marketing manager for Transidyne General. In 1970, Jill and Fred Haer founded FHC, Inc., in Ann Arbor, Michigan, and in 1977 they moved the company to Maine.
Fred is also a founder and President of STarFix, Inc., as well as Greenville Neuromodulation Center. He is on the Boards of Trustees at Thiel College and the United Way of Mid Coast Maine. Along with his wife Jill, he enthusiastically supports and participates in numerous “extended community” philanthropic and charitable activities.
Tim leads Greenville Neuromodulation Services (GNS), a wholly owned subsidiary of FHC located in northwestern Pennsylvania. In his role Tim guides GNS in its mission of providing 24/7 technical support, field repairs, and educational training programs on behalf of FHC and its portfolio.
Tim also serves as vice president of Greenville Neuromodulation Center.
Prior to joining FHC in 2009, Tim was a restoration contractor. And he continues to serve his community as a member of Team Pennsylvania's International Advisory Board, which seeks out opportunities for business and investment in the Keystone State. He attended The University of Pittsburgh and Youngstown State University as an electrical engineering student.
Andrei leads FHC Europe's Termobit facility located in Bucharest, Romania. There he and his team design neuroscience and functional neurosurgery solutions for manufacture at FHC.
Along with his work for FHC, Andrei leads the CERMO project, a novel coma monitor based on EEG reactivity to external stimuli. Also an associate professor of biomedical engineering and electronic physics at the University of Bucharest, he has to his credit some 35 publications, a few of which discuss effects of various cranial neuromodular interventions on symptoms of epilepsy and Parkinson's disease.
An FHCer since 2003, Andrei holds a doctorate and a master's degree from the University of Bucharest.